Study details
Enrolling now
Pivotal Study of the Velocity™ pAVF System
Venova Medical
NCT IDNCT07153939ClinicalTrials.gov data as of Apr 2026
Target enrollment
126
Study length
about 4.9 years
Ages
18–80
Locations
10 sites in AL, CA, FL +2
About this study
Researchers are testing a new way to create dialysis access called the Velocity Percutaneous Arteriovenous Fistula (pAVF) System. It's a minimally invasive procedure that uses a catheter instead of surgery. The trial will follow participants for up to five years to see how safe and effective this new method is.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use Velocity Percutaneous Arteriovenous Fistula
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low15%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: Freedom from Serious Adverse Events, Procedural Success, Technical Success
Body systems
Renal